Investigation Overview
September 26, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Celgene Corporation (NASDAQ:CELG) shares was launched over potential securities laws violations by Celgene and certain of its directors and officers in connection certain financial statements.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Celgene Corporation (NASDAQ:CELG) concerning whether a series of statements by Celgene regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Celgene Corporation reported that its annual Total Revenue rose from over $3.62 billion in 2010 to over $6.49 billion in 2013 and that its respective Net Income increased from $880.51 million to over $1.44 billion. Shares of Celgene Corporation (NASDAQ:CELG) split on June 26, 2014 2 :1 and grew from $83.13 per share in July 2014 to as high as $96.21 per share on September 24, 2014.